Friedreich N. Ueber degenerative atrophie der spinalen Hinterstrange. Virchow Arch Path Anat. 1863. 26:391-419.
Friedreich N. Ueber degenerative atrophie der spinalen Hinterstrange. Virchow Arch Path Anat. 1863. 27:1-26.
Marie P. Sur l'heredo-ataxie cerebelleuse.Clinique des maladies nerveuses. Semaine Med, Paris. 1893. 13:444-7.
Marie P, Foix C, Alajouanine T. De l'atrophie cerebelleuse tardive a predominance corticale. Revue Neurologique, Paris. 1922. 38:849-85; 1082-111.
Dejerine J, Thomas A. L'atrophie olivo-ponto-cerebelleuse. Nouv Icon de la Salpet. 1900. 13:330-70.
Greenfield JG. The Spino-cerebellar Degenerations. Springfield, Ill: Charles C. Thomas; 1954.
Harding AE. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. Brain. 1982 Mar. 105(Pt 1):1-28. [QxMD MEDLINE Link].
Konigsmark BW, Weiner LP. The olivopontocerebellar atrophies: a review. Medicine (Baltimore). 1970 May. 49(3):227-41. [QxMD MEDLINE Link].
Skre H, Berg K. Cerebellar ataxia and total albinism: a kindred suggesting pleitotropism or linkage. Clin Genet. 1974. 5(3):196-204. [QxMD MEDLINE Link].
Paulson H, Ammache Z. Ataxia and hereditary disorders. Neurol Clin. 2001. Aug;19(3):759-82, viii. [QxMD MEDLINE Link].
Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. 2015 Jan 15. 372 (3):249-63. [QxMD MEDLINE Link]. [Full Text].
Gilman S, Little R, Johanns J, et al. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology. 2000 Aug 22. 55(4):527-32. [QxMD MEDLINE Link].
Jellinger KA. Neuropathological spectrum of synucleinopathies. Mov Disord. 2003 Sep. 18 Suppl 6:S2-12. [QxMD MEDLINE Link].
Kuzdas-Wood D, Stefanova N, Jellinger KA, Seppi K, Schlossmacher MG, Poewe W, et al. Towards translational therapies for multiple system atrophy. Prog Neurobiol. 2014 Jul. 118:19-35. [QxMD MEDLINE Link]. [Full Text].
Stefanova N, Kaufmann WA, Humpel C, Poewe W, Wenning GK. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human a-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol. 2012 Apr 11. [QxMD MEDLINE Link].
Pikkarainen M, Hartikainen P, Soininen H, Alafuzoff I. Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry. Cerebellum. 2011 Dec. 10(4):720-31. [QxMD MEDLINE Link].
Meissner WG, Flabeau O, Perez P, Taillard J, Marquant F, Dupouy S, et al. Accuracy of portable polygraphy for the diagnosis of sleep apnea in multiple system atrophy. Sleep Med. 2014 Apr. 15(4):476-9. [QxMD MEDLINE Link].
Jellinger KA. Neuropathology of multiple system atrophy: New thoughts about pathogenesis. Mov Disord. 2014 Oct 9. [QxMD MEDLINE Link].
Banfi S, Servadio A, Chung MY, et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet. 1994 Aug. 7(4):513-20. [QxMD MEDLINE Link].
Burk K, Abele M, Fetter M, Dichgans J, Skalej M, Laccone F, et al. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 1996 Oct. 119 ( Pt 5):1497-505. [QxMD MEDLINE Link].
Fickler A. Klinische und pathologisch-anatomische Beitraege zu den Erkrankungen des Kleinhirns. Dtsch Z Nervenheilk. 1911. 41:306-75.
Winkler C. A case of olivo-pontine cerebellar atrophy and our conceptions of neo- and palaio-cerebellum. Schweiz Arch Neurol Psychiat. 1923. 13:684-702.
Schut JW, Haymaker W. Hereditary ataxia: pathologic study of 5 cases of common ancestry. J Neuropath Clin Neurol. 1951. 1:183-213.
Carter HR, Sukavajana C. Familial cerebello-olivary degeneration with late development of rigidity and dementia. Neurology. 1956 Dec. 6(12):876-84. [QxMD MEDLINE Link].
Illarioshkin SN, Tanaka H, Markova ED, et al. X-linked nonprogressive congenital cerebellar hypoplasia: clinical description and mapping to chromosome Xq. Ann Neurol. 1996 Jul. 40(1):75-83. [QxMD MEDLINE Link].
Bertini E, des Portes V, Zanni G, et al. X-linked congenital ataxia: a clinical and genetic study. Am J Med Genet. 2000 May 1. 92(1):53-6. [QxMD MEDLINE Link].
Chou SM, Gilbert EF, Chun RW, et al. Infantile olivopontocerebellar atrophy with spinal muscular atrophy (infantile OPCA + SMA). Clin Neuropathol. 1990 Jan-Feb. 9(1):21-32. [QxMD MEDLINE Link].
Barth PG. Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset. Brain Dev. 1993 Nov-Dec. 15(6):411-22. [QxMD MEDLINE Link].
Rajab A, Mochida GH, Hill A, et al. A novel form of pontocerebellar hypoplasia maps to chromosome 7q11-21. Neurology. 2003 May 27. 60(10):1664-7. [QxMD MEDLINE Link].
Albrecht S, Schneider MC, Belmont J, Armstrong DL. Fatal infantile encephalopathy with olivopontocerebellar hypoplasia and micrencephaly. Report of three siblings. Acta Neuropathol (Berl). 1993. 85(4):394-9. [QxMD MEDLINE Link].
Patel MS, Becker LE, Toi A, et al. Severe, fetal-onset form of olivopontocerebellar hypoplasia in three sibs: PCH type 5?. Am J Med Genet A. 2006 Mar 15. 140(6):594-603. [QxMD MEDLINE Link].
Colella S, Nardo T, Botta E, et al. Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum. Hum Mol Genet. 2000 May 1. 9(8):1171-5. [QxMD MEDLINE Link].
Kanda T, Oda M, Yonezawa M, et al. Peripheral neuropathy in xeroderma pigmentosum. Brain. 1990 Aug. 113 (Pt 4):1025-44. [QxMD MEDLINE Link].
De Sanctis C, Cacchione A. L'idiozia xerodermica [xerodermic idiocy]. Rivista Sperimentale di Freniatria e Medicina Legale delle Alienazioni Mentali. 1932. 56:269-92.
Agamanolis DP, Potter JL, Naito HK, et al. Lipoprotein disorder, cirrhosis, and olivopontocerebellar degeneration in two siblings. Neurology. 1986 May. 36(5):674-81. [QxMD MEDLINE Link].
Harding BN, Dunger DB, Grant DB, Erdohazi M. Familial olivopontocerebellar atrophy with neonatal onset: a recessively inherited syndrome with systemic and biochemical abnormalities. J Neurol Neurosurg Psychiatry. 1988 Mar. 51(3):385-90. [QxMD MEDLINE Link].
Menzel P. Beitrage zur Kenntnis der hereditaren Ataxie und Kleinhirnatrophie. Archiv fur Psychiatrie und Nervenkrankheiten, Berlin. 1891. 22:160-90.
Waggoner RW, Lowenberg K, Speicher KG. Hereditary cerebellar ataxia: report of a case and genetic study. Arch Neurol Psychiat. 1938. 39:570-86.
Schut JW. Hereditary ataxia: clinical study through six generations. Arch Neurol Psychiat. 1950. 63:535-68.
Orr HT, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 1993 Jul. 4(3):221-6. [QxMD MEDLINE Link].
Donato SD, Mariotti C, Taroni F. Spinocerebellar ataxia type 1. Handb Clin Neurol. 2012. 103:399-421. [QxMD MEDLINE Link].
Boller F, Segarra JM. Spino-pontine degeneration. Eur Neurol. 1969. 2(6):356-73. [QxMD MEDLINE Link].
Wadia NH, Swami RK. A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families). Brain. 1971. 94(2):359-74. [QxMD MEDLINE Link].
Ueyama H, Kumamoto T, Nagao S, et al. Clinical and genetic studies of spinocerebellar ataxia type 2 in Japanese kindreds. Acta Neurol Scand. 1998 Dec. 98(6):427-32. [QxMD MEDLINE Link].
Nakano KK, Dawson DM, Spence A. Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts. Neurology. 1972 Jan. 22(1):49-55. [QxMD MEDLINE Link].
Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet. 1994 Nov. 8(3):221-8. [QxMD MEDLINE Link].
Gardner K, Alderson K, Galster B. Autosomal dominant spinocerebellar ataxia: clinical description of a distinct hereditary ataxia and genetic localization to chromosome 16 (SCA4) in a Utah kindred. Neurology. 1994. 44:A361 only.
Hellenbroich Y, Bubel S, Pawlack H, et al. Refinement of the spinocerebellar ataxia type 4 locus in a large German family and exclusion of CAG repeat expansions in this region. J Neurol. 2003 Jun. 250(6):668-71. [QxMD MEDLINE Link].
Ishikawa K, Toru S, Tsunemi T, et al. An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein. Am J Hum Genet. 2005 Aug. 77(2):280-96. [QxMD MEDLINE Link].
Ikeda Y, Dick KA, Weatherspoon MR, et al. Spectrin mutations cause spinocerebellar ataxia type 5. Nat Genet. 2006 Feb. 38(2):184-90. [QxMD MEDLINE Link].
Subramony SH, Fratkin JD, Manyam BV, Currier RD. Dominantly inherited cerebello-olivary atrophy is not due to a mutation at the spinocerebellar ataxia-I, Machado-Joseph disease, or Dentato-Rubro-Pallido-Luysian atrophy locus. Mov Disord. 1996 Mar. 11(2):174-80. [QxMD MEDLINE Link].
Zhuchenko O, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997 Jan. 15(1):62-9. [QxMD MEDLINE Link].
David G, Abbas N, Stevanin G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997 Sep. 17(1):65-70. [QxMD MEDLINE Link].
Koob MD, Moseley ML, Schut LJ, et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet. 1999 Apr. 21(4):379-84. [QxMD MEDLINE Link].
Ikeda Y, Shizuka M, Watanabe M, et al. Molecular and clinical analyses of spinocerebellar ataxia type 8 in Japan. Neurology. 2000 Feb 22. 54(4):950-5. [QxMD MEDLINE Link].
Factor SA, Qian J, Lava NS, et al. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Ann Neurol. 2005 Mar. 57(3):462-3. [QxMD MEDLINE Link].
Grewal RP, Tayag E, Figueroa KP, et al. Clinical and genetic analysis of a distinct autosomal dominant spinocerebellar ataxia. Neurology. 1998 Nov. 51(5):1423-6. [QxMD MEDLINE Link].
Zu L, Figueroa KP, Grewal R, Pulst SM. Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22. Am J Hum Genet. 1999 Feb. 64(2):594-9. [QxMD MEDLINE Link].
Grewal RP, Achari M, Matsuura T, et al. Clinical features and ATTCT repeat expansion in spinocerebellar ataxia type 10. Arch Neurol. 2002 Aug. 59(8):1285-90. [QxMD MEDLINE Link].
Worth PF, Giunti P, Gardner-Thorpe C, et al. Autosomal dominant cerebellar ataxia type III: linkage in a large British family to a 7.6-cM region on chromosome 15q14-21.3. Am J Hum Genet. 1999 Aug. 65(2):420-6. [QxMD MEDLINE Link].
Holmes SE, O'Hearn EE, McInnis MG, Gorelick-Feldman DA, et al. Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat Genet. 1999 Dec. 23(4):391-2. [QxMD MEDLINE Link].
Fujigasaki H, Verma IC, Camuzat A, et al. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol. 2001 Jan. 49(1):117-21. [QxMD MEDLINE Link].
Waters MF, Minassian NA, Stevanin G, et al. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet. 2006 Apr. 38(4):447-51. [QxMD MEDLINE Link].
Yamashita I, Sasaki H, Yabe I, et al. A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann Neurol. 2000 Aug. 48(2):156-63. [QxMD MEDLINE Link].
Brkanac Z, Bylenok L, Fernandez M, et al. A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. Arch Neurol. 2002 Aug. 59(8):1291-5. [QxMD MEDLINE Link].
Chen DH, Brkanac Z, Verlinde CL, et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet. 2003 Apr. 72(4):839-49. [QxMD MEDLINE Link].
Yabe I, Sasaki H, Chen DH, et al. Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. Arch Neurol. 2003 Dec. 60(12):1749-51. [QxMD MEDLINE Link].
Storey E, Gardner RJ, Knight MA, et al. A new autosomal dominant pure cerebellar ataxia. Neurology. 2001 Nov 27. 57(10):1913-5. [QxMD MEDLINE Link].
Knight MA, Kennerson ML, Anney RJ, et al. Spinocerebellar ataxia type 15 (sca15) maps to 3p24.2-3pter: exclusion of the ITPR1 gene, the human orthologue of an ataxic mouse mutant. Neurobiol Dis. 2003 Jul. 13(2):147-57. [QxMD MEDLINE Link].
Hara K, Fukushima T, Suzuki T, et al. Japanese SCA families with an unusual phenotype linked to a locus overlapping with SCA15 locus. Neurology. 2004 Feb 24. 62(4):648-51. [QxMD MEDLINE Link].
Miyoshi Y, Yamada T, Tanimura M, et al. A novel autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1-24.1. Neurology. 2001 Jul 10. 57(1):96-100. [QxMD MEDLINE Link].
Nakamura K, Jeong SY, Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet. 2001 Jul 1. 10(14):1441-8. [QxMD MEDLINE Link].
Rolfs A, Koeppen AH, Bauer I, et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol. 2003 Sep. 54(3):367-75. [QxMD MEDLINE Link].
Maltecca F, Filla A, Castaldo I, et al. Intergenerational instability and marked anticipation in SCA-17. Neurology. 2003 Nov 25. 61(10):1441-3. [QxMD MEDLINE Link].
Brkanac Z, Fernandez M, Matsushita M, et al. Autosomal dominant sensory/motor neuropathy with Ataxia (SMNA): Linkage to chromosome 7q22-q32. Am J Med Genet. 2002 May 8. 114(4):450-7. [QxMD MEDLINE Link].
Schelhaas HJ, Ippel PF, Hageman G, et al. Clinical and genetic analysis of a four-generation family with a distinct autosomal dominant cerebellar ataxia. J Neurol. 2001 Feb. 248(2):113-20. [QxMD MEDLINE Link].
Verbeek DS, Schelhaas JH, Ippel EF, et al. Identification of a novel SCA locus (SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21. Hum Genet. 2002 Oct. 111(4-5):388-93. [QxMD MEDLINE Link].
Chung MY, Lu YC, Cheng NC, Soong BW. A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. Brain. 2003. June; 126(Pt 6):1293-9. [QxMD MEDLINE Link].
Schelhaas HJ, Verbeek DS, Van de Warrenburg BP, Sinke RJ. SCA19 and SCA22: evidence for one locus with a worldwide distribution. Brain. 2004 Jan. 127(Pt 1):E6; author reply E7. [QxMD MEDLINE Link].
Knight MA, Gardner RJ, Bahlo M, et al. Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. Brain. 2004 May. 127(Pt 5):1172-81. [QxMD MEDLINE Link].
Devos D, Schraen-Maschke S, Vuillaume I, et al. Clinical features and genetic analysis of a new form of spinocerebellar ataxia. Neurology. 2001 Jan 23. 56(2):234-8. [QxMD MEDLINE Link].
Vuillaume I, Devos D, Schraen-Maschke S, et al. A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1. Ann Neurol. 2002 Nov. 52(5):666-70. [QxMD MEDLINE Link].
Verbeek DS, van de Warrenburg BP, Wesseling P, et al. Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3. Brain. 2004 Nov. 127(Pt 11):2551-7. [QxMD MEDLINE Link].
Stevanin G, Bouslam N, Thobois S, et al. Spinocerebellar ataxia with sensory neuropathy (SCA25) maps to chromosome 2p. Ann Neurol. 2004 Jan. 55(1):97-104. [QxMD MEDLINE Link].
Yu GY, Howell MJ, Roller MJ, et al. Spinocerebellar ataxia type 26 maps to chromosome 19p13.3 adjacent to SCA6. Ann Neurol. 2005 Mar. 57(3):349-54. [QxMD MEDLINE Link].
van Swieten JC, Brusse E, de Graaf BM, et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet. 2003 Jan. 72(1):191-9. [QxMD MEDLINE Link].
Cagnoli C, Mariotti C, Taroni F, et al. SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2. Brain. 2006 Jan. 129(Pt 1):235-42. [QxMD MEDLINE Link].
Naito H, Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology. 1982 Aug. 32(8):798-807. [QxMD MEDLINE Link].
Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994 Jan. 6(1):9-13. [QxMD MEDLINE Link].
VanDyke DH, Griggs RC, Murphy MJ, Goldstein MN. Hereditary myokymia and periodic ataxia. J Neurol Sci. 1975 May. 25(1):109-18. [QxMD MEDLINE Link].
Hanson PA, Martinez LB, Cassidy R. Contractures, continuous muscle discharges, and titubation. Ann Neurol. 1977 Feb. 1(2):120-4. [QxMD MEDLINE Link].
Gancher ST, Nutt JG. Autosomal dominant episodic ataxia: a heterogeneous syndrome. Mov Disord. 1986. 1(4):239-53. [QxMD MEDLINE Link].
Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994 Oct. 8(2):136-40. [QxMD MEDLINE Link].
Brandt T, Strupp M. Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo). Audiol Neurootol. 1997 Nov-Dec. 2(6):373-83. [QxMD MEDLINE Link].
Eunson LH, Rea R, Zuberi SM, et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol. 2000 Oct. 48(4):647-56. [QxMD MEDLINE Link].
Parker HL. Periodic ataxia. Collected Papers of the Mayo Clinic. 1946. 642-5.
White JC. Familial periodic nystagmus, vertigo, and ataxia. Arch Neurol. 1969 Mar. 20(3):276-80. [QxMD MEDLINE Link].
Subramony SH, Schott K, Raike RS, et al. Novel CACNA1A mutation causes febrile episodic ataxia with interictal cerebellar deficits. Ann Neurol. 2003 Dec. 54(6):725-31. [QxMD MEDLINE Link].
Spacey SD, Materek LA, Szczygielski BI, Bird TD. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol. 2005 Feb. 62(2):314-6. [QxMD MEDLINE Link].
Imbrici P, Eunson LH, Graves TD, et al. Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology. 2005 Sep 27. 65(6):944-6. [QxMD MEDLINE Link].
Steckley JL, Ebers GC, Cader MZ, McLachlan RS. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology. 2001 Oct 23. 57(8):1499-502. [QxMD MEDLINE Link].
Cader MZ, Steckley JL, Dyment DA, et al. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology. 2005 Jul 12. 65(1):156-8. [QxMD MEDLINE Link].
Farmer TW, Mustain VM. Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations. Arch Neurol. 1963 May. 8:471-80. [QxMD MEDLINE Link].
Vance JM, Pericak-Vance MA, Payne CS. Linkage and genetic analysis in adult onset periodic vestibulo-cerebellar ataxia: report of a new family. Am J Hum Genet. 1984. 36:78S.
Damji KF, Allingham RR, Pollock SC, et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch Neurol. 1996 Apr. 53(4):338-44. [QxMD MEDLINE Link].
Escayg A, Jones JM, Kearney JA, et al. Calcium channel beta 4 (CACNB4): human ortholog of the mouse epilepsy gene lethargic. Genomics. 1998 May 15. 50(1):14-22. [QxMD MEDLINE Link].
Escayg A, De Waard M, Lee DD, et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet. 2000 May. 66(5):1531-9. [QxMD MEDLINE Link].
Herrmann A, Braathen GJ, Russell MB. [Episodic ataxias]. Tidsskr Nor Laegeforen. 2005 Aug 11. 125(15):2005-7. [QxMD MEDLINE Link].
Auburger G, Ratzlaff T, Lunkes A, et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics. 1996 Jan 1. 31(1):90-4. [QxMD MEDLINE Link].
Müller U, Steinberger D, Németh AH. Clinical and molecular genetics of primary dystonias. Neurogenetics. 1998 Mar. 1(3):165-77. [QxMD MEDLINE Link].
Ferguson FR, Critchley M. A clinical study of an heredo-familial disease resembling disseminated sclerosis. Brain. 1929. 52:203-25.
Gayle Jr RF, Williams JP. A familial disease of the central nervous system resembling multiple sclerosis. Sth Med J. 1933. 26:242-6.
Mahloudji M. Hereditary spastic ataxia simulating disseminated sclerosis. J Neurol Neurosurg Psychiatry. 1963 Dec. 26:511-3. [QxMD MEDLINE Link].
Meijer IA, Hand CK, Grewal KK, et al. A locus for autosomal dominant hereditary spastic ataxia, SAX1, maps to chromosome 12p13. Am J Hum Genet. 2002 Mar. 70(3):763-9. [QxMD MEDLINE Link].
Grewal KK, Stefanelli MG, Meijer IA, et al. A founder effect in three large Newfoundland families with a novel clinically variable spastic ataxia and supranuclear gaze palsy. Am J Med Genet A. 2004. Dec 15;131(3):249-54. [QxMD MEDLINE Link].
Brooks DJ, Seppi K, Neuroimaging Working Group on MSA. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord. 2009 May 15. 24 (7):949-64. [QxMD MEDLINE Link].
Kim HJ, Jeon B, Fung VSC. Role of Magnetic Resonance Imaging in the Diagnosis of Multiple System Atrophy. Mov Disord Clin Pract. 2017 Jan-Feb. 4 (1):12-20. [QxMD MEDLINE Link].
Aguiar P, Pardo J, Arias M, Quintáns B, Fernández-Prieto M, Martínez-Regueiro R, et al. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36. Mov Disord. 2017 Feb. 32 (2):264-273. [QxMD MEDLINE Link]. [Full Text].
Ochrynik T, Bulski T, Modzelewski M, Szatkowski M. Olivopontocerebellar atrophy in MRI spectroscopy- case report. Pol J Radiol. 2007. 72(pt 1):100-2.
Takei A, Hamada T, Yabe I, Sasaki H. Treatment of cerebellar ataxia with 5-HT1A agonist. Cerebellum. 2005. 4(3):211-5. [QxMD MEDLINE Link].
Ogawa M. Pharmacological treatments of cerebellar ataxia. Cerebellum. 2004. 3(2):107-11. [QxMD MEDLINE Link].
Assadi M, Campellone JV, Janson CG, Veloski JJ, Schwartzman RJ, Leone P. Treatment of spinocerebellar ataxia with buspirone. J Neurol Sci. 2007 Sep 15. 260(1-2):143-6. [QxMD MEDLINE Link].
Dluzen DE, McDermott JL, Liu B. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. Neurotoxicol Teratol. 1996 Sep-Oct. 18(5):603-6. [QxMD MEDLINE Link].
Al Sweidi S, Sánchez MG, Bourque M, Morissette M, Dluzen D, Di Paolo T. Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease. J Neuroendocrinol. 2012 Jan. 24(1):48-61. [QxMD MEDLINE Link].
D'Astous M, Morissette M, Di Paolo T. Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist. Neuropharmacology. 2004 Dec. 47(8):1180-8. [QxMD MEDLINE Link].
Gardiner SA, Morrison MF, Mozley PD, Mozley LH, Brensinger C, Bilker W, et al. Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am J Geriatr Psychiatry. 2004 Nov-Dec. 12(6):621-30. [QxMD MEDLINE Link].
Heo JH, Lee ST, Chu K, Kim M. The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy. J Neurol Sci. 2008 Aug 15. 271(1-2):87-90. [QxMD MEDLINE Link].
Ristori G, Romano S, Visconti A, Cannoni S, Spadaro M, Frontali M, et al. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology. 2010 Mar 9. 74(10):839-45. [QxMD MEDLINE Link].
Landers M, Adams M, Acosta K, Fox A. Challenge-oriented gait and balance training in sporadic olivopontocerebellar atrophy: a case study. J Neurol Phys Ther. 2009 Sep. 33(3):160-8. [QxMD MEDLINE Link].
Armstrong RA, Lantos PL, Cairns NJ. Spatial patterns of alpha-synuclein positive glial cytoplasmic inclusions in multiple system atrophy. Mov Disord. 2004 Jan. 19(1):109-12. [QxMD MEDLINE Link].
Barth PG, Blennow G, Lenard HG, et al. The syndrome of autosomal recessive pontocerebellar hypoplasia, microcephaly, and extrapyramidal dyskinesia (pontocerebellar hypoplasia type 2): compiled data from 10 pedigrees. Neurology. 1995 Feb. 45(2):311-7. [QxMD MEDLINE Link].
Barth PG, Vrensen GF, Uylings HB, et al. Inherited syndrome of microcephaly, dyskinesia and pontocerebellar hypoplasia: a systemic atrophy with early onset. J Neurol Sci. 1990 Jun. 97(1):25-42. [QxMD MEDLINE Link].
Berciano J. Olivopontocerebellar atrophy. A review of 117 cases. J Neurol Sci. 1982 Feb. 53(2):253-72. [QxMD MEDLINE Link].
Berciano J, Boesch S, Pérez-Ramos JM, Wenning GK. Olivopontocerebellar atrophy: toward a better nosological definition. Mov Disord. 2006 Oct. 21(10):1607-13. [QxMD MEDLINE Link].
Berciano J, Tolosa E. Olivopontocerebellar atrophy. Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. Baltimore, Md: Williams & Wilkins; 1993. 163-89.
Berent S, Giordani B, Gilman S, et al. Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy. Brain Cogn. 2002 Nov. 50(2):194-206. [QxMD MEDLINE Link].
Bird TD. Hereditary Ataxia Overview. GeneReviews. 2006. [Full Text].
Boder E, Sedgwick RP. Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics. 1958. Apr; 21(4):526-54. [QxMD MEDLINE Link].
Brown S. On hereditary ataxia, with a series of twenty-one cases. Brain. 1892. 15:250-82.
Cervinkova M, Mandakova P, Síma P. Changes in proliferation activity and relative distributions of lymphoid cell subpopulations in congenitally athymic nu/nu mice and Lurcher mice with spontaneous olivopontocerebellar degeneration. Folia Microbiol (Praha). 2006. 51(5):497-505. [QxMD MEDLINE Link].
Chokroverty S, Khedekar R, Derby B, et al. Pathology of olivopontocerebellar atrophy with glutamate dehydrogenase deficiency. Neurology. 1984 Nov. 34(11):1451-5. [QxMD MEDLINE Link].
Dekoskey ST, Kaufer DI, Lopez OL. Bradley WG, Daroff, RB, Fenichel GM, Jankovic J, eds. Neurology in Clinical Practice. Boston, Mass: Butterworth-Heinemann; 2005. 1928.
Duvoisin RC, Chokroverty S, Lepore F, Nicklas W. Glutamate dehydrogenase deficiency in patients with olivopontocerebellar atrophy. Neurology. 1983 Oct. 33(10):1322-6. [QxMD MEDLINE Link].
Fahn S, Przedborski S. Parkinsonism: multiple system atrophy. Rowland L, ed. Merritt's Neurology. 11th ed. New York, NY: Lippincott Williams & Wilkins; 2005. 836-7.
Hammond EJ, Wilder BJ. Evoked potentials in olivopontocerebellar atrophy. Arch Neurol. 1983 Jun. 40(6):366-9. [QxMD MEDLINE Link].
Holmes GM. A form of familial degeneration of the cerebellum. Brain. 1907. 30:466-89.
Ishizawa K, Komori T, Arai N, Mizutani T, Hirose T. Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system). Neuropathology. 2008 Jun. 28(3):249-57. [QxMD MEDLINE Link].
Koeppen AH. The hereditary ataxias. J Neuropathol Exp Neurol. 1998 Jun. 57(6):531-43. [QxMD MEDLINE Link].
Kofler M, Muller J, Seppi K, Wenning GK. Exaggerated auditory startle responses in multiple system atrophy: a comparative study of parkinson and cerebellar subtypes. Clin Neurophysiol. 2003 Mar. 114(3):541-7. [QxMD MEDLINE Link].
Kuriyama N, Mizuno T, Iida A, et al. Autonomic nervous evaluation in the early stages of olivopontocerebellar atrophy. Auton Neurosci. 2005 Dec 30. 123(1-2):87-93. [QxMD MEDLINE Link].
Landis DM, Rosenberg RN, Landis SC, et al. Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities. Arch Neurol. 1974 Nov. 31(5):295-307. [QxMD MEDLINE Link].
Louis-Bar D. Sur un syndrome progressif cormprenant des telangiectasies capillaires cutanees et conjonctivales symetriques, e disposition naevoïde et des troubles cerebelleux. Confinia Neurologica. 1941. 4:32-42.
Luo W, Ouyang Z, Guo Y, Chen Y, Ding M. Spinal muscular atrophy combined with sporadic olivopontocerebellar atrophy. Clin Neurol Neurosurg. 2008 Sep. 110(8):855-8. [QxMD MEDLINE Link].
Mascalchi M, Cosottini M, Lolli F, Salvi F, Tessa C, Macucci M, et al. Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia. Radiology. 2002 May. 223(2):371-8. [QxMD MEDLINE Link].
McKusick VA et al. Online Mendelian Inheritance in Man (OMIM). [Full Text].
Nonne M. Uber eine eigentumliche familiare Erkrankungsform des Zentralnervensystems. Archiv Psychiatrie Nervenkrankheiten, Berlin. 1891. 22:283-316.
Oshima K. Olivopontocerebellar atrophy (OPCA) in corticobasal degeneration (CBD): a quantitative study of three cases of atypical CBD: OI-A22. Neuropathology. 2007. 27(pt 2):166.
Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 1989 Dec. 94(1-3):79-100. [QxMD MEDLINE Link].
Papp MI, Lantos PL. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci. 1992 Feb. 107(2):172-82. [QxMD MEDLINE Link].
Penney JB. Multiple systems atrophy and nonfamilial olivopontocerebellar atrophy are the same disease. Ann Neurol. 1995 May. 37(5):553-4. [QxMD MEDLINE Link].
Rinne JO, Burn DJ, Mathias CJ, et al. Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol. 1995 May. 37(5):568-73. [QxMD MEDLINE Link].
Roper AH, Brown RH. Adam's and Victor's The Principles of Neurology. 8th ed. New York, NY: McGraw-Hill; 2005. 925-6; 935-6.
Sorbi S, Tonini S, Giannini E, et al. Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy. Ann Neurol. 1986 Mar. 19(3):239-45. [QxMD MEDLINE Link].
Syllaba L, Henner K. Contribution a l'etude de l'indendance de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe du resau vasculaire conjonctival, integrite psychique. Revue neurologique. 1926. 1:541-60.
Testa D, Tiranti V, Girotti F. Unusual association of sporadic olivopontocerebellar atrophy and motor neuron disease. Neurol Sci. 2002 Dec. 23(5):243-5. [QxMD MEDLINE Link].